Tonix Pharmaceuticals Holding Corp. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Tonix Pharmaceuticals Holding Corp. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 156M shares, a 776% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 156M +138M +776% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 9.83M -930K -8.64% Jun 30, 2024 10-Q 2024-08-16
Q1 2024 73.7M +10M +15.8% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 2.08M -10.3M -83.2% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 17.8M -35.6M -66.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 10.8M -20.9M -66% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 63.7M -489M -88.5% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 12.4M -3.27M -20.9% Dec 31, 2022 10-K 2024-04-01
Q3 2022 53.3M -350M -86.8% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 31.7M -315M -90.9% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 553M +229M +70.7% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 15.6M -190M -92.4% Dec 31, 2021 10-K 2023-03-13
Q3 2021 404M +264M +188% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 346M +338M +3960% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 324M +275M +556% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 206M +197M +2315% Dec 31, 2020 10-K 2022-03-14
Q3 2020 140M +139M +8798% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 8.53M +2.19M +34.6% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 49.4M +43.3M +710% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 8.53M +8.2M +2496% Dec 31, 2019 10-K 2021-03-15
Q3 2019 1.58M -8.91M -85% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 6.34M -2.48M -28.1% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 6.09M -1.92M -24% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 329K -457K -58.2% Dec 31, 2018 10-K 2020-03-24
Q3 2018 10.5M +2.9M +38.2% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 8.82M +1.33M +17.8% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 8.01M +3.85M +92.5% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 786K -3.13M -79.9% Dec 31, 2017 10-K/A 2019-03-18
Q3 2017 7.58M -21.8M -74.2% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 7.49M -17.6M -70.1% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 4.16M -14.7M -78% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 3.92M +2.04M +108% Dec 31, 2016 10-K 2018-03-09
Q3 2016 29.4M +10.5M +55.9% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 25.1M +8.94M +55.4% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 18.9M +2.75M +17.1% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 1.88M -8.92M -82.6% Dec 31, 2015 10-K 2017-04-13
Q3 2015 18.8M +8.1M +75.4% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 16.1M +6.2M +62.5% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 16.1M +6.24M +63% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 10.8M +4.98M +85.6% Dec 31, 2014 10-K 2016-03-03
Q3 2014 10.7M +5.86M +120% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 9.93M +7.74M +352% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 9.9M +7.74M +359% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 5.82M +3.66M +170% Dec 31, 2013 10-K 2015-02-27
Q3 2013 4.88M -29.4M -85.8% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 2.2M -32.1M -93.6% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 2.16M -32.1M -93.7% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 2.16M +806K +59.5% Dec 31, 2012 10-K 2014-03-28
Q3 2012 34.3M Sep 30, 2012 10-Q 2012-11-14
Q2 2012 34.3M Jun 30, 2012 10-Q 2012-08-13
Q1 2012 34.3M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 1.35M -16.7M -92.5% Dec 31, 2011 10-K/A 2013-11-22
Q4 2010 18M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.